Original-Research  105  0 Kommentare Marley Spoon Group SE (von NuWays AG): Kaufen

Reason for the research: Update
Recommendation: Kaufen
from: 02.05.2024
Target price: EUR 7.00
Target price on sight of: 12 Monaten
Last rating change:
Analyst: Mark Schüssler

Healthy Q1 results // FY'24 guidance confirmed; chg.

On Tuesday, Marley Spoon Group ('MSG') released healthy Q1'24 and final FY'23 consolidated results that were in line with expectations. Q1'24 sales came in at EUR 80.7m or -12% yoy (excluding bistroMD c. EUR 76m; eNuW: EUR 75.6m). Cautious consumer behavior in the meal-kit segment continued to weigh on sales as the number of active subscribers fell 23% yoy to 194k (eNuW: 189k) - the effect of which was more pronounced for Europe and Australia than for the US - while revenue from bistroMD partially offset this decline and had a noticeable impact on Q1'24 group sales of c. EUR 5m (eNuW).

Importantly, after several quarters of decline, MSG was able to observe bottoming-out effects in its subscriber base (+0.5% qoq) as well as a recovery in both order frequency (+5% qoq to 6.5; +2% yoy) and basket size (+3% qoq to EUR 64; +11% yoy) indicating a return to healthy growth and KPI levels. This positive development was overwhelmingly driven by (1) a higher-quality subscriber base with enhanced retention levels on the back of a rectified voucher strategy in H2'23, (2) higher-priced and largersized plan items and (3) an overall stabilizing consumer sentiment.
While topline headwinds persisted, MSG managed to expand its industry-leading contribution margin in Q1 to 34.4% (+335bps yoy, eNuW: 32.5%) on account of reduced voucher and promotional activity and first cost savings in fulfilment (-37% yoy to EUR 9.2m) derived from the FreshRealm partnership. Notably, MSG translated a higher contribution margin into a healthy operating EBITDA margin of 0.2% for Q1 (c. +700bps yoy) impacted by an increased marketing efficiency (-33% yoy to EUR 13.8m) and a more streamlined G&A setup (-3% yoy to c. EUR 21.5m excluding one-offs) as cost reduction measures from automation, centralization, and the closure of underutilized operations began to kick in.

This promising Q1 performance led the company to confirm its FY'24 guidance, expecting sales to grow by a single-digit percentage figure (eNuW: +9% yoy) and a flat contribution margin of c. 31.5% (eNuW: 31.8%). Operating EBITDA is seen to grow to a positive mid-single-digit figure (eNuW: EUR 2m). In our view, this guidance looks achievable and - aided by a promising strategic outlook and operational progress towards group profitability - MSG looks set to disproportionately benefit from an eventual return of consumer confidence.

We reiterate our BUY rating with an unchanged PT of EUR 7.00 based on DCF.

You can download the research here:
http://www.more-ir.de/d/29579.pdf
For additional information visit our website
www.nuways-ag.com/research.

Lesen Sie auch

Downgrade

Morgan Stanley stuft China-Aktie Baidu ab – was jetzt?

vor 22 Minuten

Versicherungs-Titan

Allianz: Analysten rechnen mit höherem Gewinn, heben Kursziele an

vor 1 Stunde

Ausverkauf bei Kryptobörse

Coinbase-Aktie bricht trotz Bitcoin-Run ein: Was ist da los?

heute 11:21

Gold gegen Bitcoin

Welches Asset besitzt mehr Potential?

gestern 18:30

Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++

transmitted by EQS Group AG.

The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

°

Die 468 SPAC II Registered (A) Aktie wird zum Zeitpunkt der Veröffentlichung der Nachricht mit einem Plus von +7,69 % und einem Kurs von 2,80EUR auf Xetra (30. April 2024, 17:35 Uhr) gehandelt.